MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Myoclonus: Etiology and Pathogenesis"

  • MDS Virtual Congress 2020

    An unusual phenotype of spinocerebellar ataxia type 12

    K. Neeraja, V. Holla, S. Prasad, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

    Objective: To describe a case of spinocerebellar ataxia type 12 (SCA-12) with an unusual phenotype. Background: SCA-12 is a rare autosomal dominant cerebellar ataxia which…
  • MDS Virtual Congress 2020

    Amantadine-induced negative myoclonus in a patient with Parkinson’s disease: A case report

    M. Vuong, L. Poon, A. Lee, J.R Zuzuárregui (San Francisco, CA, USA)

    Objective: To report a case of amantadine-induced negative myoclonus in a patient with Parkinson’s disease. Background: Parkinson’s disease is a progressive neurodegenerative disease that involves…
  • MDS Virtual Congress 2020

    The distinct EEG signature of celiac disease-related cortical myoclonus

    E. Swinkin, K. Lizarraga, M. Algarni, L. Dominguez, J. Baarbe, J. Saravanamuttu, R. Chen, E. Slow, A. Lang, R. Wennberg (Toronto, ON, Canada)

    Objective: To describe a novel motor cortex (M1) electroencephalogram (EEG) abnormality distinct to celiac disease (CD)-related cortical myoclonus and to explore its relationship with cerebellar-M1…
  • 2019 International Congress

    A novel intronic pentanucleotide TTTGA repeat insertion in SAMD12 causes familial cortical myoclonic tremor with epilepsy type 1

    ZD. Cen, Y. Chen, S. Chen, XH. Chen, B. Wang, F. Xie, OY. Zhiyuan, ZW. Jiang, AS. Fu, B. Hu, HM. Yin, X. Qiu, F. Yu, XP. Du, WC. Has, YX. Liu, HT. Wang, DH. Yang, LB. Wang, CY. Liu, JF. Xiao, BR. Zhang, W. Luo (Hangzhou, China)

    Objective: To identify the genetic cause in a familial cortical myoclonic tremor with epilepsy (FCMTE) pedigree without reported pathogenic(TTTCA)n insertions. Background: FCMTE is an autosomal…
  • 2019 International Congress

    Acute Onset Parkinsonism Secondary to West Nile Virus Encephalitis

    M. Purbaugh, F. Ali, T. Diesing, A. Hellman (Omaha, NE, USA)

    Objective: To demonstrate a case of acute Parkinsonism caused by West Nile Virus (WNV) Encephalitis that improved with resolution of the infection. Background: Acute onset…
  • 2019 International Congress

    Regardless of impaired renal function, negative myoclonus can be induced by gabapetin and pregabalin

    DY. Kwon, MH. Park (Gyenggi-Do, Republic of Korea)

    Objective: This study evaluated pregabalin- or gabapentin-induced negative myoclonus according to renal function. Background: Gabapentin and pregabalin are commonly used to control neuropathic pain and epilepsy.…
  • 2019 International Congress

    Drug-induced Negative Myoclonus: A Case Report

    L. Lerjefors, M. Mainardi, A. Antonini, M. Carecchio (Padova, Italy)

    Objective: To report on a case of drug-induced negative myoclonus in a patient with a complex oral therapy. Background: Myoclonus is a shock-like jerk due…
  • 2019 International Congress

    Adult-Onset Parainfectious Opsoclonus-Myoclonus: Report of Two Cases

    MI. Gaston, I. Rubio, J. Muruzabal, R. Larumbe, M. Martin, L. Martinez (Pamplona, Spain)

    Objective: Present two cases of Adult-Onset parainfectious Opsoclonus-Myoclonus Syndrome with fast and good recovery Background: Adult-Onset Opsoclonus-Myoclonus  (AOMS) is a rare disorder. Two main causes…
  • 2019 International Congress

    Steroid-responsive myoclonus in the context of pembrolizumab treatment: a novel neurological phenotype.

    M. Murphy, S. O'Dowd, M. Alexander (Dublin, Ireland)

    Objective: To outline a novel immunologically-mediated neurological adverse event associated with the use of a medication class which has an expanding range of applications [1].…
  • 2019 International Congress

    High dose amantadine therapy may cause increased falling in Parkinson’s patients

    L. Verhagen Metman (Chicago, IL, USA)

    Objective: To report a possible association between high dose amantadine and increased falling in patients with Parkinson’s disease (PD). Background: Amantadine is used in PD…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley